See also this year's filing and all EDGAR filings for this company.
PDF Report 0001941029_2026_Advanced_Biomed_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.0686161483328006, 'aggregate_val': 6512343, 'exp_sum': 6992115, 'exp_to_value': {'IntangibleAssets': 0, 'AssetsNonCurrent': 479772, 'AssetsCurrent': 6032571, 'PropertyPlantAndEquipment': 331346, 'remainder_Assets': 148426}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001941029, Advanced Biomed Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 479,772 |
| 2 | AssetsCurrent | 6,032,571 |
| 3 | PropertyPlantAndEquipment | 331,346 |
| 4 | remainder_Assets | -331,346 |
| 5 | LongTermLiabilities | 145,651 |
| 6 | LiabilitiesCurrent | 2,889,128 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 2,111,265 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 909,771 |
| 16 | remainder_Expenses | 0 |
| 17 | remainder_Revenues | 0 |
| 18 | remainder_NetIncome | -237,933 |
| 19 | remainder_ComprehensiveNetIncome | 218,346 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 6,512,343 |
| 1 | Liabilities | 3,034,779 |
| 2 | Expenses | 3,021,036 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 3,477,564 |
| 5 | NetIncome | -3,258,969 |
| 6 | ComprehensiveNetIncome | -3,040,623 |
| 7 | BaseVar | 6,512,218 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.419 |
| 9 | EconomicCapitalRatio | 1.26 |